 You look at Humira. Humira is a blockbuster medication for arthritis. And after two decades of the brand name drug being the only version available, last year, lower cost alternatives came on the market. And collectively, employers, insurance programs, patients, they stood to save up to $6 billion a year switching to these copycat drugs.